• The specific situation of the patient. Unless otherwise provided for by national regulations,
off-label use of medication should be limited to situations where it is in the patient's interest …

MicroRNAs (miRNAs) are small regulatory molecules post-transcriptionally suppressing
mRNA activity. Many miRNAs in various organisms have been cloned but many unknown …

Abstract The Canadian Cardiovascular Society (CCS) atrial fibrillation (AF) guidelines
program was developed to aid clinicians in the management of these complex patients, as …

Background Atrial fibrillation is the most frequent cardiac arrhythmia. It has been estimated
that 6–12 million people worldwide will suffer this condition in the US by 2050 and 17.9 …

Supraventricular arrhythmias are common and patients are often symptomatic, requiring
management with drugs and electrophysiological procedures. The ESC published …

Background: Low detection and nonadherence are major problems in current management
approaches for patients with suspected atrial fibrillation (AF). Mobile health devices may …

Background The risk of stroke is heterogeneous across different groups of patients with atrial
fibrillation (AF), being dependent on the presence of various stroke risk factors. We provide …

Abstract Objectives: The WATCH AF (SmartWATCHes for Detection of Atrial Fibrillation) trial
compared the diagnostic accuracy to detect atrial fibrillation (AF) by a smartwatch-based …

There is an increasing proportion of the general population surviving to old age with
significant chronic disease, multi-morbidity, and disability. The prevalence of pre-frail state …

Background The most common type of arrhythmia in the USA and in European countries is
atrial fibrillation (AF). The prevalence of AF is increasing worldwide with advances in …